TRANSCODE THERAPEUTICS, INC. Stock Split Ratio
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Stock Split Ratio of 3.57% as of 2025-05-15, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-08-14
- TRANSCODE THERAPEUTICS, INC. stockholders' equity note, stock split, conversion ratio for the quarter ending 2024-03-31 was 100.00%.
- TRANSCODE THERAPEUTICS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2023 was 5.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|---|
| 2025-05-15 | 3.57% 10-Q · filed 2026-08-14 | |||||
| 2024-12-31 | 3.00% 10-K · filed 2025-04-15 | |||||
| 2024-12-04 | 3.00% 10-Q · filed 2026-08-14 | |||||
| 2024-09-30 | 100.00% 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | 100.00% 10-Q · filed 2024-08-14 | |||||
| 2024-03-31 | 100.00% 10-Q · filed 2024-05-15 | |||||
| 2024-01-31 | 2.50% 10-K · filed 2025-04-15 | |||||
| 2024-01-16 | 2.50% 10-Q · filed 2026-08-14 | |||||
| 2023-12-31 | 5.00% 10-K · filed 2024-04-01 | |||||
| 2023-09-30 | 5.00% 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | 5.00% 10-Q · filed 2023-08-14 | |||||
| 2023-05-31 | 5.00% 10-K · filed 2025-04-15 | |||||
| 2023-05-23 | 5.00% 10-Q · filed 2026-08-14 | |||||
| 2021-03-22 | 164.86% 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |